These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37787042)

  • 1. Biological function of C-X-C Motif Chemokine Ligand 1 gene (CXCL1) in ovarian malignant tumors.
    Li Z; Huang N; Zhang W; Li L
    Hum Exp Toxicol; 2023; 42():9603271231203392. PubMed ID: 37787042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of CXCL1 gene expression on the biological function of epithelial ovarian carcinoma cells in vitro].
    Zhang W; Huang N; Wang Q; Yang ZJ; Li L
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):109-13. PubMed ID: 23714664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.
    Liu CH; Jing XN; Liu XL; Qin SY; Liu MW; Hou CH
    J Ovarian Res; 2020 Aug; 13(1):92. PubMed ID: 32782028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
    Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
    Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer.
    Sun J; Yuan J
    Bioengineered; 2022 Mar; 13(3):7579-7591. PubMed ID: 35264061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
    Dong YL; Kabir SM; Lee ES; Son DS
    PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-145-5p regulates cell proliferation and cell migration in colon cancer by inhibiting chemokine (C-X-C motif) ligand 1 and integrin α2.
    Zhuang W; Niu T; Li Z
    Bioengineered; 2021 Dec; 12(2):9909-9917. PubMed ID: 34860147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
    Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
    J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
    Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.
    Lv QY; Zou HZ; Xu YY; Shao ZY; Wu RQ; Li KJ; Deng X; Gu DN; Jiang HX; Su M; Zou CL
    Bioengineered; 2021 Dec; 12(1):3711-3725. PubMed ID: 34269159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer.
    Miyake M; Lawton A; Goodison S; Urquidi V; Rosser CJ
    Pathol Res Pract; 2014 Feb; 210(2):74-8. PubMed ID: 24252309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
    Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation.
    Park GY; Pathak HB; Godwin AK; Kwon Y
    Cell Oncol (Dordr); 2021 Feb; 44(1):77-92. PubMed ID: 32910411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 cells regulate the production of CXCL1 in breast cancer.
    Ma K; Yang L; Shen R; Kong B; Chen W; Liang J; Tang G; Zhang B
    Int Immunopharmacol; 2018 Mar; 56():320-329. PubMed ID: 29438938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
    Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
    Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
    Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
    Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL1 promoted the migration and invasion abilities of oral cancer cells and might serve as a promising marker of prognosis in tongue cancer.
    Zhang S; Dong Y; Zhao S; Bi F; Xuan M; Zhu G; Guo W; Zhang Z
    J Oral Pathol Med; 2023 Aug; 52(7):583-592. PubMed ID: 36829264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.